The short answer
Small cell lung cancer grows faster, is staged as limited or extensive, and is treated with platinum-etoposide plus immunotherapy, while non-small cell lung cancer is driven by molecular testing.
Non-small cell lung cancer makes up roughly 80% to 85% of cases and small cell roughly 10% to 15%.
SCLC is staged as limited or extensive rather than by the four-stage TNM system used for NSCLC.
Platinum-etoposide is the SCLC backbone; immunotherapy (atezolizumab or durvalumab) is added in extensive stage.
In December 2024 the FDA approved durvalumab after chemoradiation for limited-stage SCLC, where median overall survival was 55.9 months versus 33.4 months.
Choose how you want to understand this
The full explanation.
Two diseases that share an organ
Lung cancer is not one disease. Non-small cell lung cancer accounts for roughly 80% to 85% of cases, and small cell lung cancer for roughly 10% to 15%. They are told apart under the microscope, and the difference drives almost everything that follows: how fast things move, how they are staged, what treatments are used, and what the timeline looks like.
Non-small cell lung cancer includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. These are grouped together because their treatment and outlook are broadly similar.
Pace
Small cell lung cancer is, in NCI's description, "a type of fast-growing cancer." It tends to spread early, often before symptoms appear, and it frequently starts near the center of the chest. It is strongly linked to smoking.
This pace changes the shape of care. In SCLC, treatment usually begins quickly, sometimes within days of diagnosis, and the initial response to chemotherapy is often dramatic and rapid. The difficulty is durability: shrinkage is common, and keeping it shrunk is the hard part.
Non-small cell lung cancer generally moves more slowly. There is usually time for full molecular testing before starting, and that waiting period, though hard, often changes the plan.
Staging works differently
SCLC has historically used a two-part system. Limited stage means the cancer is confined to one side of the chest and can be covered by a single radiation field. Extensive stage means it has spread beyond that, including to the other lung, fluid around the lung, or distant sites. NCI describes limited stage as cancer "in the lung where it started" that "may have spread to the area between the lungs or to the lymph nodes above the collarbone," and extensive stage as spread beyond that.
NSCLC uses the standard four-stage TNM system, with stages I through IV based on tumor size, node involvement, and distant spread.
Treatment diverges sharply
For small cell lung cancer, chemotherapy is the backbone: a platinum drug (cisplatin or carboplatin) with etoposide. In limited stage, chemotherapy is given together with chest radiation. In extensive stage, an immunotherapy drug (atezolizumab or durvalumab) is added to platinum-etoposide and then continued.
Limited-stage disease also changed recently. In December 2024 the FDA approved durvalumab after concurrent chemoradiation for limited-stage SCLC, based on the ADRIATIC trial, where median overall survival was 55.9 months versus 33.4 months with placebo. Radiation to the brain to prevent spread, called prophylactic cranial irradiation, is discussed with some patients; brain MRI surveillance is an alternative in some settings.
Non-small cell lung cancer is where biomarker testing dominates. Early-stage disease may be treated with surgery, often with chemotherapy or immunotherapy before or after. Advanced NSCLC is sorted by molecular results: EGFR, ALK, ROS1, BRAF, RET, MET, KRAS G12C, NTRK, and others each have matched oral targeted drugs, and PD-L1 expression guides immunotherapy. Routine broad molecular testing is standard in advanced NSCLC and is not standard in SCLC, because SCLC has not yet yielded the same set of actionable targets.
Being honest about outlook
NCI states that "for most people with small cell lung cancer, current treatments do not cure the cancer." That is real, and so is the fact that limited-stage disease is treated with curative intent and that some people do achieve long remissions. Extensive-stage survival has improved with immunotherapy, and newer agents such as tarlatamab have been approved for previously treated disease.
For NSCLC, outcomes vary enormously by stage and by whether a targetable alteration is present. Some people with advanced, targetable disease live many years on oral therapy.
What to confirm
Ask which type you have and, for NSCLC, which subtype. Ask whether full molecular and PD-L1 testing was done, on tissue or blood, and when results will return. Ask whether your SCLC is limited or extensive stage, and whether brain imaging has been done. Ask what the goal of treatment is: cure, or control.
Sources
Words to know
Tap any term to see what it means.
Common questions
Why is my treatment starting so much faster than my friend's?
Small cell lung cancer is fast-growing and often begins treatment within days. Non-small cell lung cancer usually allows time for full molecular testing first, because those results frequently change the plan. Different pace, different sequence.
What does limited stage versus extensive stage mean?
Limited stage means the cancer is confined to one side of the chest and can be covered by a single radiation field, which allows chemotherapy and radiation to be given together. Extensive stage means spread beyond that, including the other lung, fluid around the lung, or distant sites.
Why was I not offered targeted therapy?
Matched oral targeted drugs exist for alterations such as EGFR, ALK, ROS1, BRAF, RET, MET, KRAS G12C, and NTRK, which are found in non-small cell lung cancer. Small cell lung cancer does not currently have an equivalent set of targets, so chemotherapy and immunotherapy remain the backbone.
What is prophylactic cranial irradiation?
Radiation to the whole brain given to prevent spread there, discussed with some people whose SCLC has responded well to treatment. Regular brain MRI surveillance is an alternative approach in some settings, and the trade-offs including memory effects are worth discussing.
Can small cell lung cancer be cured?
NCI states that for most people with SCLC current treatments do not cure the cancer. Limited-stage disease is treated with curative intent, some people achieve long remissions, and extensive-stage survival has improved with immunotherapy. Asking your team whether your treatment aims at cure or control gives a clearer answer than general figures.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2028-07-29
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share